| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Pharmacology and 2 Cardiovascular Research, Berlex Biosciences, Richmond, California 94804
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Atherosclerosis develops and progresses spontaneously in apolipoprotein E-knockout (apoE-KO) mice. A direct consequence of atherosclerosis is an increase in vascular stiffness. Pulse wave velocity (PWV) has been used to assess the stiffness of large vessels and was found to be increased in patients with atherosclerosis. In the present study, aortic stiffness was assessed by PWV in 4- and 13-mo-old apoE-KO mice and age-matched controls (C57BL/6J). In 13-mo-old apoE-KO mice with extensive atherosclerotic lesions in the aorta (61 ± 4%), PWV increased significantly (3.8 ± 0.2 m/s) compared with controls (2.9 ± 0.2 m/s). Endothelial nitric oxide (EDNO)-mediated vasorelaxation in response to ACh was markedly diminished in the aortic rings isolated from 13-mo-old apoE-KO mice compared with age-matched controls. In contrast, in 4-mo-old apoE-KO mice with only moderate atherosclerotic lesions in the aorta (23 ± 5%), there were no significant changes in PWV and EDNO-mediated relaxation compared with controls. Blood pressure was not different among the four groups of mice. There were no significant differences in endothelium-independent vascular responses to sodium nitroprusside among different groups investigated. Histological evaluation revealed focal fragmentation of the elastic laminae in the aortic walls of 13-mo-old apoE-KO mice. These results demonstrate for the first time that aortic stiffness determined by PWV increases in 13-mo-old apoE-KO mice. Endothelial dysfunction and elastic destruction in vascular wall caused by atherosclerosis may have contributed.
compliance; elastin degradation; endothelium-dependent relaxation; nitric oxide
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
A COMMON CONSEQUENCE of atherosclerosis is an increase in the stiffness of the aorta and major arteries, resulting in decreased vascular elasticity and compliance (16, 18). The stiffness of conduit vessels can be estimated by pulse wave velocity (PWV). The stiffer the vessel, the faster the pulse wave moving along the aorta. PWV is an accepted parameter for estimating elasticity and compliance of large vessels in humans (2), nonhuman primates (12, 13), dogs (22), rabbits (30), rats (3), and mice (15). It has been used as a surrogate marker for vascular diseases (4, 18), including atherosclerosis (30). For example, PWV has been used in laboratory animal studies to evaluate the antiatherosclerotic effect of a fish oil in rabbits fed high cholesterol (30) and in clinical studies to evaluate the therapeutic effects of antihypertensive agents on the elastic properties of vascular wall (4).
A properly functioning endothelium produces nitric oxide (NO) and other
vasoactive substances that are able to protect the vascular wall
against noxious stimuli by multiple mechanisms of action (11). NO
has been shown to inhibit platelet aggregation and adhesion, to
attenuate leukocyte and monocyte adhesion and transmigration, to
suppress smooth muscle proliferation, and, most well known, to induce
vasorelaxation (6). NO has also been shown to react with oxygen free
radicals (27) and interferes with redox-sensitive transcription of
proinflammatory molecules (vascular cell adhesion molecule 1, intercellular adhesion molecule 1, monocyte chemoattractant protein 1, macrophage colony-stimulating factor, and others) by inhibiting the
activation of nuclear factor-
B (25).
Apolipoprotein E (apoE) is an important mediator for hepatic metabolic clearance of circulating cholesterol. When apoE polypeptide is dysfunctional or absent, severe hyperlipidemia occurs in humans or animal models. Atherosclerosis develops and progresses spontaneously in apoE-knockout (apoE-KO) mice. Histological changes in atherosclerotic plaques in the aorta and other large vessels of apoE-KO mice have been extensively investigated. However, the changes in physical properties as well as endothelial function of the aorta in connection to the progression of atherosclerosis have not been well characterized in this animal model of atherosclerosis. Therefore, the present study was designed to investigate the relationship among the aortic elasticity, as measured by PWV; the degree of endothelial dysfunction, as measured by ACh-induced relaxation of isolated aortic rings; and the morphological changes of the aorta, as determined by plaque area and histological examination.
| |
MATERIALS AND METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Animals
Experiments were carried out in 4- and 13-mo-old apoE-KO and age-matched control (C57BL/6J) mice obtained from Jackson Laboratories (Bar Harbor, ME). Animals were kept in a room at controlled temperature (24°C) and lighting (14:10-h light-dark cycle) with free access to food and tap water.At death, blood samples were collected by cardiac puncture from the animals into serum separator tubes (Microtainer, Becton Dickinson, NJ) and centrifuged at 1,000 g for 10 min. Serum total cholesterol levels were measured by Consolidated Veterinary Diagnostics (West Sacramento, CA).
In Vivo Measurement of PWV As an Index for Aortic Elasticity
Surgical preparation.
Mice were anesthetized with a mixture of ketamine (120 mg/kg, Ketaset;
Fort Dodge Laboratories, Fort Dodge, IA) and xylazine (7 mg/kg, Rompun;
Bayer, Shawnee Mission, KS) injected intramuscularly. A Millar Mikro-tip pressure transducer
(1.4-Fr, Millar Instruments, Houston, TX) was inserted via the left
carotid artery into the aortic arch for measuring intravascular
arterial blood pressure (proximal pressure wave). The abdominal aorta
was exposed through a suprapubic incision. Another Millar catheter
(1.8-Fr) was positioned underneath the abdominal aorta at a site just
above the iliac bifurcation and was oriented to record extravascular
tonometric pressure wave outside the vessel (distal pressure wave). The
best signals were obtained by orienting the catheter tip at a right angle to the vessel axis and the side-mounted sensor flat against the
vessel. The catheter was lifted slightly to maintain contact and to
applanate the vessel against the sensor. By taking simultaneous measurements of extravascular tonometric pressure and Doppler velocity
waveforms at the same site on the mouse aorta, Hartley et al. (15)
demonstrated that upstrokes of the pressure and velocity waves occur
simultaneously within the resolution of the measurement technique. When
the surgery was completed, all wounds were closed to minimize
evaporative loss of fluid.
|
Experimental procedures. The mice were placed on a heating board at 37°C to maintain body temperature. When blood pressure and heart rate had been stable for ~30 min, the pressure waves from the aortic arch and abdominal aorta were recorded simultaneously for at least 30 min. The signals were digitized and stored using a data acquisition system (PowerLab 16/s, ADInstruments, Castle Hill, New South Wales, Australia). Samples were acquired at a rate of 1,000 Hz. Because the Millar pressure transducer has a frequency response from flat to 10,000 Hz, it is able to provide high-fidelity measurements of the pressure waveforms of the mice.
Data analysis. Systolic arterial pressure (SAP), diastolic arterial pressure (DAP), pulse pressure (PP), mean arterial blood pressure (MAP), and heart rate (HR) were calculated by the data acquisition system from the proximal pressure wave. The propagation time for the pulse wave moving from the aortic arch to the abdominal aorta was measured by the time delay between the upstrokes (foot) of each pressure wave front. Measurements reported in the text were made by averaging at least 10 normal consecutive cardiac cycles. After the experiments were completed, the animals were euthanized with an overdose of pentobarbital sodium (200 mg/kg) and the full length of the aorta was exposed. The distance between the two measurement sites was determined using a damp cotton thread stuck onto the aorta between the tips of the two pressure transducers and marked. The thread was then removed and laid straight for measurement of the distance between the two marks. PWV was then calculated by dividing the distance by the pulse wave propagation time in units of meters per second.
Ex Vivo Measurements of Endothelium-Dependent and -Independent Vasorelaxation of the Aortic Rings in Organ Chambers
Mice were euthanized with CO2. The thoracic aortas were removed from the animals and cut into 2-mm segments. The aortic rings were placed inside a 15-ml tissue bath filled with Krebs (composition in mM: 118 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2 MgSO4, 1.17 KH2PO4, 20 NaHCO3, 0.026 EDTA, and 11 glucose) at 37°C, bubbled with 95% O2-5% CO2, and attached to a force transducer (model F30, Hugo Sachs Electronic) coupled to a data acquisition system (MP100, Biopac system) for measurement of isometric tension.After the initial equilibration period of 1 h at a resting tension of
0.5 g, aortic rings were contracted twice with KCl (40 mM) followed by
U-46619 (3 × 10
8 M), a dose that submaximally
contracted the vessel to ~70% of the maximal response. After the
plateau was reached, cumulative concentration-response curves to ACh
and sodium nitroprusside (SNP) were sequentially generated. Responses
are expressed in percent relaxation. The 
log molar concentration
of the drug required to produce 50% of the maximum response was
determined by computer-assisted interactive nonlinear regression
analysis (GraphPad Prism, San Diego, CA).
Morphological Examination of the Aorta
Atherosclerotic plaque analysis. The proximal portion of the thoracic aorta up to the aortic origin was isolated, cleaned from the adherent connective tissue, fixed with 10% Formalin, cut open longitudinally, and pinned down individually on silicon-coated petri dishes. Atherosclerotic plaque areas are visible without staining. The images of the open luminal surface of the vessels were captured at a resolution of 512 × 512 by a red-green-blue three-chip charge-coupled device digital camera (Sony) mounted on a dissecting microscope (Nikon SMZ-2T) and recorded on an attached computer in 24-bit true image format. The analyses of the images were performed using C-Simple software (C. Imaging 1208, Compix, Mars, PA). The atherosclerotic plaque area was quantified and expressed as a percentage of the total luminal surface area of the thoracic aorta.
Histological examination of the aortic wall. Cross sections of the proximal aorta were obtained from 4- and 13-mo-old mice. All sections were embedded in paraffin, cut at 5-µm thicknesses, and stained with hematoxylin and eosin. Elastin van Geison stain was also used to show details of the elastic laminae. Slides were viewed on a Zeiss Axioskop microscope and photographed with an attached digital camera (HC-2000, Fuji). Images were printed on a digital printer (Pictrography 3000, Fuji).
Statistical Analysis
Results are presented as means ± SE for the number of animals (n) indicated. Multiple comparisons of the mean values were performed by a two-way (group and age) ANOVA followed, if significance was indicated, by a subsequent Student-Newman-Keuls test for repeated comparisons. The data were tested for homogeneity of variances before the two-way ANOVA was performed. Differences were considered to be statistically significant when the P value was <0.05. The statistical analysis was processed with Statistica software (StatSoft, Tulsa, OK).| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
PWV in the Aorta: In Vivo Measurement
PWV was slightly, but not significantly, higher in 4-mo-old apoE-KO than in control mice (Fig. 1). In 13-mo-old control mice, PWV was not statistically different from that in the 4-mo-old controls. PWV of the 13-mo-old apoE-KO was significantly increased compared with both age-matched controls and 4-mo-old apoE-KO mice. There were no statistically significant differences in MAP, SAP, DAP, and PP among the four experimental groups (Table 1). Although the age of the animals at the time of the experiments was the same for apoE-KO and control mice, body weight was lower in apoE-KO (28 ± 0 and 34 ± 1 g) than in control (30 ± 1 and 40 ± 1 g) mice of 4 and 13 mo of age, respectively. However, the distance between the proximal and distal measurement sites was not different between apoE-KO (38 ± 1 and 42 ± 1 mm) and control (38 ± 1 and 41 ± 1 mm) mice of 4 and 13 mo of age, respectively. Serum cholesterol levels were high in apoE-KO mice of 4 (480 ± 45 mg/dl) and 13 (730 ± 78 mg/dl) mo of age compared with controls of 4 (87 ± 4 mg/dl) and 13 (89 ± 7 mg/dl) mo of age.
|
Vasorelaxation of the Aortic Rings: In Vitro Organ Chamber Assay
Endothelial NO (EDNO)-mediated relaxation of the aortic rings in response to ACh was not significantly different between 4-mo-old apoE-KO and control mice (Fig. 2A). The maximal response and calculated half-maximal dose of ACh also were not significantly different between these two groups (Table 2). In 13-mo-old mice, however, the relaxation to ACh was significantly attenuated in apoE-KO mice compared with age-matched controls (Fig. 2B). The maximal response was significantly lower in apoE-KO than in control mice, whereas the half-maximal dose of ACh was not different between these two groups (Table 2). In contrast, endothelium-independent relaxation in response to SNP in both 4- and 13-mo-old apoE-KO mice was not affected compared with that in age-matched controls (Fig. 3). The maximal relaxation and half-maximal dose of SNP also were not significantly different among different groups (Table 2).
|
|
|
Morphological Analysis of the Aorta
Atherosclerotic plaques in the aorta.
Image analysis of the open luminal surface of the Formalin-fixed aortic
arch and thoracic aorta showed no detectable vascular lesions in either
4- or 13-mo-old controls (Fig. 4,
left). In the 4-mo-old apoE-KO mice (n = 8), 23 ± 5%
of the luminal surface area of the aortic arch and thoracic aorta was
covered by plaques (Fig. 4, middle). In the 13-mo-old apoE-KO
group (n = 6), over 61 ± 4% of the luminal surface area was
covered by atherogenic plaques (Fig. 4, right).
|
Histological findings in the aortic wall.
Microscopic examination revealed normal-appearing thoracic aorta in all
the sections from control mice of both 4 (Fig.
5A) and 13 mo of age (Fig.
5C) and in the section from an apoE-KO mouse of 4 mo of age
(Fig. 5B). There was no evidence of endothelial damage or
intimal hyperplasia. In contrast, atherosclerotic plaques were
identified in sections obtained from 13-mo-old apoE-KO mice as
evidenced by intimal thickening, foam cell accumulation, and a thin
collagen cap (Fig. 5D). As shown in Fig.
6, the elastic laminae underneath the
plaque from the aorta of a 13-mo-old apoE-KO mouse had focal
fragmentation as well as local destruction. Cells of
apparent smooth muscle origin can be seen bridging the region from the
vessel media to the plaque area.
|
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
The results of this study demonstrate for the first time that changes in PWV and endothelial function develop during the progression of atherosclerosis in apoE-KO mice. At 13 mo of age, PWV was significantly higher and EDNO-mediated vasorelaxation was attenuated in apoE-KO mice, with extensive atherosclerotic lesions and elastic laminar fragmentation in the aortic wall compared with age-matched controls as well as the 4-mo-old apoE-KO mice, without visible elastic laminar fragmentation in the aorta.
PWV can be influenced by several factors such as age, blood pressure, and hypercholesterolemia. It has been reported that the aorta becomes stiffer and less distensible with age (10). However, we found no significant difference in PWV between old and young control mice, suggesting that in the 9-mo interval that we examined, age-related vascular stiffening could not explain the increase in PWV in the 13-mo-old apoE-KO mice. High blood pressure also has been known to increase PWV (22). Because blood pressure was not significantly different among the four experimental groups under the conditions in which PWV was determined, it is not a contributing factor in this study. Hypercholesterolemia has also been shown to correlate to PWV increases (19). However, in the present study, cholesterol level alone is unlikely to influence our results directly because there were no measurable differences in PWV between the 4- mo-old apoE-KO and control mice despite the high levels of circulating lipids in the apoE-KO group. In support of this view, Farra et al. (12) reported that resuming a normal chow diet in cynomolgus monkeys after a high-cholesterol diet for 18 mo did not reverse the increase in PWV in the first 6 mo. After the atherogenic diet had been removed for 12 mo in these monkeys, PWV significantly decreased, and this decrease was also accompanied by a decrease in the ratio of intimal (plaque) to medial area in the aorta by that time (12). Therefore, high cholesterol does not seem to directly affect PWV. It is more likely that it increases vascular stiffness by promoting the progression of atherosclerotic lesions and vascular remodeling.
The pathology of atherosclerosis is characterized by massive infiltration of macrophages and foam cells into the aortic wall. Increased production of active matrix metalloproteinases from these cells triggers degradation of insoluble elastin and fibrillar collagen in the aortic wall (17). Indeed, the present study demonstrated focal breakdown of the elastic laminae in the media underneath the atherosclerotic plaques in the older apoE-KO mice. This result is consistent with the findings by Carmeliet et al. (8), who also reported fragmentation of elastic laminae and rupture of all elastic layers across the media of the aortic wall in apoE-KO mice. The integrity of the medial elastin in the conduit vessels is a major determinant of the arterial elasticity and the capacitive function of these arteries. Therefore, we postulate that the increase in PWV in the old apoE-KO mice could largely be caused by the breakdown of the elastin in the aortic wall of these animals.
One of the earliest events in atherogenesis is increased low-density lipoprotein (LDL) accumulation in the artery wall. Rutledge et al. (29) demonstrated that lipoprotein lipase bound to glycosaminoglycans increases LDL permeating across the endothelial layer, thus increasing retention and decreasing efflux of LDL from the artery wall. The trapped LDL becomes oxidized and has been found to decrease arterial elasticity, probably by affecting the matrix cross-link structure and contents in the vessel wall (31). This may also contribute to the aortic stiffening in old apoE-KO mice.
Endothelial dysfunction is characterized by impaired EDNO-mediated
relaxation in atherosclerosis. Numerous studies have demonstrated impaired EDNO-mediated vasodilation in the coronary arteries (20, 26,
32-34) as well as systemically (1, 24) in patients with atherosclerosis or risk factors for atherosclerosis. The present study
also demonstrated significant endothelial dysfunction in isolated
aortic rings of the 13-mo-old apoE-KO mice. In contrast, endothelium-independent vasorelaxation in response to NO donor was not
significantly affected in the same animals, indicating that the
responsiveness of the vascular smooth muscle to NO is preserved. EDNO
is believed to be an antiatherogenic molecule that antagonizes several
pathophysiological processes contributing to plaque development
simultaneously (5-7). Lack of EDNO can be considered a key
progression factor in the development of atherosclerosis. The
pathogenic link between decreased EDNO production and atherogenesis is
proven by animal experiments demonstrating accelerated atherosclerosis after chronic inhibition of NO formation by
N
-nitro-L-arginine methylester
(L-NAME) (9). The increase in PWV may be a consequence of
endothelial dysfunction. In a separate study in rats, we observed that
acute inhibition of NO synthase (NOS) by L-NAME increased
PWV independent of the increase in blood pressure, suggesting that lack
of NO production contributes to the decrease in vascular elasticity
(14). In support of this hypothesis, Matz et al. (21) demonstrated that
inhibition of NOS in rabbits is also associated with augmentation of
the arterial pressure wave reflection, a consequence of increased
arterial stiffness. Infusion of ACh, a stimulant of EDNO release, had
the opposite effect, which can be blocked by NOS inhibition (21). In
addition, we also demonstrated that chronic inhibition of NOS by
L-NAME for 3 wk further increased PWV compared with that in acute L-NAME-treated rats (14). This additional
increase in PWV is probably the result of abnormal vascular remodeling.
Numaguchi et al. (23) demonstrated that chronic treatment with
L-NAME in rats resulted in a significantly abnormal
remodeling of the aortic wall. In addition, studies with endothelial
constitutive NOS-deficient mice also showed abnormal vascular
remodeling (28). Thus, it is possible that abnormal vascular remodeling
caused by chronic attenuation of EDNO production in atherosclerosis
contributes to the increase in PWV.
In summary, with the use of PWV measurement, the present study revealed for the first time an increase in aortic stiffness in 13-mo-old apoE-KO mice, accompanied by severe atherosclerosis and fragmentation of the elastic laminae in the aortic wall as well as attenuated EDNO-mediated relaxation of the aortic rings. The decrease in the aortic elasticity is probably related to both the lack of EDNO and elastic destruction caused by atherosclerotic lesions. Thus our results demonstrate that PWV can be used as a surrogate end point or marker for estimating the progression of atherosclerosis in apoE-KO mice.
| |
ACKNOWLEDGEMENTS |
|---|
V. Da Cunha is a visiting scientist at Berlex Biosciences from Federal University of Espirito Santo, Brazil, and is supported by Coordenacao de Aperfercoamento de Pessoal de Nivel Superior (0680/98-2).
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: Y.-X. Wang, Dept. of Pharmacology, Berlex Biosciences, PO Box 4099, 15049 San Pablo Ave., Richmond, CA 94804-0099 (E-mail: jim_wang{at}berlex.com).
Received 16 April 1999; accepted in final form 16 August 1999.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Anderson, T. J.,
M. D. Gerhard,
I. T. Meredith,
F. Charbonneau,
D. Delagrange,
M. A. Creager,
A. P. Selwyn,
and
P. Ganz.
Systemic nature of endothelial dysfunction in atherosclerosis.
Am. J. Cardiol.
75:
71B-74B,
1995[Medline].
2.
Asmar, R. G.,
J. A. Topouchian,
A. Benetos,
F. A. Sayegh,
J. J. Mourad,
and
M. E. Safar.
Non-invasive evaluation of arterial abnormalities in hypertensive patients (Abstract).
J. Hypertens.
15:
S99,
1997.
3.
Atkinson, J.,
P. Poitevin,
J. M. Chillon,
I. Lartaud,
and
B. Levy.
Vascular Ca overload produced by vitamin D3 plus nicotine diminishes arterial distensibility in rats.
Am. J. Physiol. Heart Circ. Physiol.
266:
H540-H547,
1994
4.
Breithaupt-Grogler, K.,
G. Gerhardt,
G. Lehmann,
T. Notter,
and
G. G. Belz.
Blood pressure and aortic elastic properties
verapamil SR/trandolapril compared with a metoprolol/hydrochlorothiazide combination therapy.
Int. J. Clin. Pharmacol. Ther.
36:
425-431,
1998[ISI][Medline].
5.
Busse, R.,
and
I. Fleming.
Regulation and functional consequences of endothelial nitric oxide formation.
Ann. Med.
27:
331-340,
1995[ISI][Medline].
6.
Busse, R.,
I. Fleming,
and
V. B. Schini.
Nitric oxide formation in the vascular wall: regulation and functional implications.
Curr. Top. Microbiol. Immunol.
196:
7-18,
1995[Medline].
7.
Busse, R.,
M. Hecker,
and
I. Fleming.
Control of nitric oxide and prostacyclin synthesis in endothelial cells.
Arzneimittelforschung
44:
392-396,
1994[Medline].
8.
Carmeliet, P.,
L. Moons,
R. Lijnen,
M. Baes,
V. Lemaitre,
P. Tipping,
A. Drew,
Y. Eeckhout,
S. Shapiro,
F. Lupu,
and
D. Collen.
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation.
Nat. Genet.
17:
439-444,
1997[ISI][Medline].
9.
Cayatte, A. J.,
J. J. Palacino,
K. Horten,
and
R. A. Cohen.
Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits.
Arterioscler. Thromb.
14:
753-759,
1994
10.
Cockcroft, J. R.,
I. B. Wilkinson,
and
D. J. Webb.
The Trevor Howell Lecture. Age, arterial stiffness and the endothelium.
Age Ageing
26, Suppl.4:
53-60,
1997
11.
De Caterina, R.,
P. Libby,
H. B. Peng,
V. J. Thannickal,
T. B. Rajavashisth,
M. A. Gimbrone, Jr.,
W. S. Shin,
and
J. K. Liao.
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.
J. Clin. Invest.
96:
60-68,
1995.
12.
Farrar, D. J.,
M. G. Bond,
W. A. Riley,
and
J. K. Sawyer.
Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys.
Circulation
83:
1754-1763,
1991
13.
Farrar, D. J.,
M. G. Bond,
J. K. Sawyer,
and
H. D. Green.
Pulse wave velocity and morphological changes associated with early atherosclerosis progression in the aortas of cynomolgus monkeys.
Cardiovasc. Res.
18:
107-118,
1984[ISI][Medline].
14.
Fitch, R. M.,
R. Vergona,
M. E. Sullivan,
and
Y.-X. Wang.
Nitric oxide synthase (NOS) inhibition decreased vascular compliance measured by pulse wave velocity (PWV) in rats (Abstract).
Nitric Oxide
2:
126,
1998.
15.
Hartley, C. J.,
G. E. Taffet,
L. H. Michael,
T. T. Pham,
and
M. L. Entman.
Noninvasive determination of pulse-wave velocity in mice.
Am. J. Physiol. Heart Circ. Physiol.
273:
H494-H500,
1997
16.
Hirai, T.,
S. Sasayama,
T. Kawasaki,
and
S. Yagi.
Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis.
Circulation
80:
78-86,
1989
17.
Holmes, D. R.,
D. Petrinec,
W. Wester,
R. W. Thompson,
and
J. M. Reilly.
Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat.
J. Surg. Res.
63:
305-309,
1996[ISI][Medline].
18.
Lehmann, E. D.,
K. D. Hopkins,
R. L. Jones,
A. G. Rudd,
and
R. G. Gosling.
Aortic distensibility in patients with cerebrovascular disease.
Clin. Sci. (Colch.)
89:
247-253,
1995[Medline].
19.
Levenson, J.,
M. Del Pino,
M. Razavian,
I. Merli,
V. Filitti,
and
A. Simon.
Hypercholesterolaemia alters arterial and blood factors related to atherosclerosis in hypertension.
Atherosclerosis
95:
171-179,
1992[ISI][Medline].
20.
Ludmer, P. L.,
A. P. Selwyn,
T. L. Shook,
R. R. Wayne,
G. H. Mudge,
R. W. Alexander,
and
P. Ganz.
Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries.
N. Engl. J. Med.
315:
1046-1051,
1986[Abstract].
21.
Matz, J.,
T. L. Andersson,
G. A. Ferns,
and
E. E. Anggard.
Dietary vitamin E increases the resistance to lipoprotein oxidation and attenuates endothelial dysfunction in the cholesterol-fed rabbit.
Atherosclerosis
110:
241-249,
1994[ISI][Medline].
22.
Nichols, W.,
and
M. F. O'Rourke.
McDonald's Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles. London: Arnold, 1998.
23.
Numaguchi, K.,
K. Egashira,
M. Takemoto,
T. Kadokami,
H. Shimokawa,
K. Sueishi,
and
A. Takeshita.
Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
Hypertension
26:
957-962,
1995
24.
Otsuji, S.,
O. Nakajima,
S. Waku,
S. Kojima,
H. Hosokawa,
I. Kinoshita,
T. Okubo,
S. Tamoto,
K. Takada,
T. Ishihara,
Attenuation of acetylcholine-induced vasoconstriction by L-arginine is related to the progression of atherosclerosis.
Am. Heart J.
129:
1094-1100,
1995[ISI][Medline].
25.
Peng, H. B.,
P. Libby,
and
J. K. Liao.
Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.
J. Biol. Chem.
270:
14214-14219,
1995
26.
Quyyumi, A. A.,
N. Dakak,
N. P. Andrews,
S. Husain,
S. Arora,
D. M. Gilligan,
J. A. Panza,
and
R. O. Cannon III.
Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.
J. Clin. Invest.
95:
1747-1755,
1995.
27.
Rubanyi, G. M.,
and
P. M. Vanhoutte.
Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle.
Am. J. Physiol. Heart Circ. Physiol.
250:
H815-H821,
1986.
28.
Rudic, R. D.,
E. G. Shesely,
N. Maeda,
O. Smithies,
S. S. Segal,
and
W. C. Sessa.
Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.
J. Clin. Invest.
101:
731-736,
1998[ISI][Medline].
29.
Rutledge, J. C.,
M. M. Woo,
A. A. Rezai,
L. K. Curtiss,
and
I. J. Goldberg.
Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products.
Circ. Res.
80:
819-828,
1997
30.
Sato, M.,
Y. Katsuki,
H. Kanehiro,
M. Iimura,
Y. Akada,
M. Mizota,
and
Y. Kunihiro.
Effects of ethyl all-cis-5,8,11,14,17-icosapentaenoate on the physical properties of arterial walls in high cholesterol diet-fed rabbits.
J. Cardiovasc. Pharmacol.
22:
1-9,
1993[ISI][Medline].
31.
Toikka, J. O.,
P. Niemi,
M. Ahotupa,
H. Niinikoski,
J. S. Viikari,
T. Ronnemaa,
J. J. Hartiala,
and
O. T. Raitakari.
Large-artery elastic properties in young men: relationships to serum lipoproteins and oxidized low-density lipoproteins.
Arterioscler. Thromb. Vasc. Biol.
19:
436-441,
1999
32.
Wennmalm, A.
Nitric oxide (NO) in the cardiovascular system: role in atherosclerosis and hypercholesterolemia.
Blood Press.
3:
279-282,
1994[Medline].
33.
Zeiher, A. M.,
H. Drexler,
B. Saurbier,
and
H. Just.
Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension.
J. Clin. Invest.
92:
652-662,
1993.
34.
Zeiher, A. M.,
H. Drexler,
H. Wollschlager,
and
H. Just.
Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis.
Circulation
84:
1984-1992,
1991
This article has been cited by other articles:
|
|
 |
|
  S. Ryoo, G. Gupta, A. Benjo, H. K. Lim, A. Camara, G. Sikka, H. K. Lim, J. Sohi, L. Santhanam, K. Soucy, et al. Endothelial Arginase II: A Novel Target for the Treatment of Atherosclerosis Circ. Res., April 25, 2008; 102(8): 923 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Soucy, S. Ryoo, A. Benjo, H. K. Lim, G. Gupta, J. S. Sohi, J. Elser, M. A. Aon, D. Nyhan, A. A. Shoukas, et al. Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to age-related vascular stiffness J Appl Physiol, December 1, 2006; 101(6): 1751 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Fitch, J. C. Rutledge, Y.-X. Wang, A. F. Powers, J.-L. Tseng, T. Clary, and G. M. Rubanyi Synergistic effect of angiotensin II and nitric oxide synthase inhibitor in increasing aortic stiffness in mice Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1190 - H1198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. White, S. Ryoo, D. Li, H. C. Champion, J. Steppan, D. Wang, D. Nyhan, A. A. Shoukas, J. M. Hare, and D. E. Berkowitz Knockdown of Arginase I Restores NO Signaling in the Vasculature of Old Rats Hypertension, February 1, 2006; 47(2): 245 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-X. Wang, B. Martin-McNulty, V. da Cunha, J. Vincelette, X. Lu, Q. Feng, M. Halks-Miller, M. Mahmoudi, M. Schroeder, B. Subramanyam, et al. Fasudil, a Rho-Kinase Inhibitor, Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice by Inhibiting Apoptosis and Proteolysis Circulation, May 3, 2005; 111(17): 2219 - 2226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Hartley, A. K. Reddy, S. Madala, M. L. Entman, L. H. Michael, and G. E. Taffet Noninvasive ultrasonic measurement of arterial wall motion in mice Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1426 - H1432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Reddy, Y.-H. Li, T. T. Pham, L. N. Ochoa, M. T. Trevino, C. J. Hartley, L. H. Michael, M. L. Entman, and G. E. Taffet Measurement of aortic input impedance in mice: effects of age on aortic stiffness Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1464 - H1470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Martin-McNulty, D. M. Tham, V. da Cunha, J. J. Ho, D. W. Wilson, J. C. Rutledge, G. G. Deng, R. Vergona, M. E. Sullivan, and Y.-X. Wang 17{beta}-Estradiol Attenuates Development of Angiotensin II-Induced Aortic Abdominal Aneurysm in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1627 - 1632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gervais, S. Pons, A. Nicoletti, C. Cosson, J.-F. Giudicelli, and C. Richer Fluvastatin Prevents Renal Dysfunction and Vascular NO Deficit in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 183 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Tham, B. Martin-McNulty, Y.-X. Wang, V. Da Cunha, D. W. Wilson, C. N. Athanassious, A. F. Powers, M. E. Sullivan, and J. C. Rutledge Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1442 - R1449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Imai, T. Shindo, K. Maemura, M. Sata, Y. Saito, Y. Kurihara, M. Akishita, J. Osuga, S. Ishibashi, K. Tobe, et al. Resistance to Neointimal Hyperplasia and Fatty Streak Formation in Mice With Adrenomedullin Overexpression Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1310 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tatchum-Talom, C. Martel, and A. Marette Influence of estrogen on aortic stiffness and endothelial function in female rats Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H491 - H498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gros, R. Van Wert, X. You, E. Thorin, and M. Husain Effects of age, gender, and blood pressure on myogenic responses of mesenteric arteries from C57BL/6 mice Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H380 - H388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-X. Wang, B. Martin-McNulty, A. D. Freay, D. A. Sukovich, M. Halks-Miller, W.-W. Li, R. Vergona, M. E. Sullivan, J. Morser, W. P. Dole, et al. Angiotensin II Increases Urokinase-Type Plasminogen Activator Expression and Induces Aneurysm in the Abdominal Aorta of Apolipoprotein E-Deficient Mice Am. J. Pathol., October 1, 2001; 159(4): 1455 - 1464. [Abstract] [Full Text]
|
|
|
|
|
|
E. Lutgens, E. D. de Muinck, S. Heeneman, and M. J.A.P. Daemen Compensatory Enlargement and Stenosis Develop in ApoE-/- and ApoE*3-Leiden Transgenic Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1359 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Fitch, R. Vergona, M. E. Sullivan, and Y.-X. Wang Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats Cardiovasc Res, August 1, 2001; 51(2): 351 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Hartley, A. K. Reddy, S. Madala, B. Martin-McNulty, R. Vergona, M. E. Sullivan, M. Halks-Miller, G. E. Taffet, L. H. Michael, M. L. Entman, et al. Hemodynamic changes in apolipoprotein E-knockout mice Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2326 - H2334. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
